Page last updated: 2024-11-02

pipobroman and Abnormalities, Autosome

pipobroman has been researched along with Abnormalities, Autosome in 2 studies

Pipobroman: An antineoplastic agent that acts by alkylation.
pipobroman : An N-acylpiperazine that is piperazine in which each of the nitrogens has been acylated by a 3-bromopropionoyl group. An anti-cancer drug.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bernasconi, P1
Boni, M1
Cavigliano, PM1
Calatroni, S1
Brusamolino, E1
Passamonti, F1
Volpe, G1
Pistorio, A1
Giardini, I1
Rocca, B1
Caresana, M1
Lazzarino, M1
Bernasconi, C1
Tefferi, A1

Other Studies

2 other studies available for pipobroman and Abnormalities, Autosome

ArticleYear
Acute myeloid leukemia (AML) having evolved from essential thrombocythemia (ET): distinctive chromosome abnormalities in patients treated with pipobroman or hydroxyurea.
    Leukemia, 2002, Volume: 16, Issue:10

    Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Chromosome Aberrations; Female; Humans; H

2002
Is hydroxyurea leukemogenic in essential thrombocythemia?
    Blood, 1998, Aug-15, Volume: 92, Issue:4

    Topics: Acute Disease; Antineoplastic Agents, Alkylating; Bone Marrow; Busulfan; Chromosome Aberrations; Chr

1998